Status:

COMPLETED

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Lead Sponsor:

Sanofi

Conditions:

Healthy

Eligibility:

All Genders

18-60 years

Phase:

PHASE3

Brief Summary

To prove the safety, in normal conditions, of the odontological use formulation of the product Cepacol Canela Power.

Eligibility Criteria

Inclusion

  • Integral buccal mucous (without oral pathologies);
  • Normal odontological exams;

Exclusion

  • Lactation or gestational risk or gestation;
  • Use of Anti-inflammatory or immunosuppression drugs 15 days before the study;
  • Being in odontological treatment;
  • Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results;
  • Personal history of allergic disease in the area to be treated;
  • Allergic or atopic history;

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00687037

Start Date

January 1 2008

Last Update

February 13 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanofi-aventis

São Paulo, São Paulo, Brazil